Search Results

Autophinib 25 mg  | 98.83%

TargetMol

Autophinib is a potent autophagy inhibitor with a novel chemotype with IC50 values of 90 and 40 nM for autophagy in starvation induced autophagy assay and rapamycin induced autophagy assay.

More Information Supplier Page

MD2-IN-1 10 mg  | 99.43%

TargetMol

MD2-IN-1 is a Myeloid differentiation protein 2 (MD2) inhibitor with a KD of 189  μM for the recombinant human MD2 (rhMD2).

More Information Supplier Page

S1RA hydrochloride 5 mg  | 99.65%

TargetMol

S1RA HCl (E-52862 HCl) is an effective and specific sigma-1 receptor(σ1R, Ki: 17 nM) antagonist, and has good selectivity against σ2R (Ki > 1000 nM).

More Information Supplier Page

S1RA hydrochloride 2 mg  | 99.65%

TargetMol

S1RA HCl (E-52862 HCl) is an effective and specific sigma-1 receptor(σ1R, Ki: 17 nM) antagonist, and has good selectivity against σ2R (Ki > 1000 nM).

More Information Supplier Page

S1RA hydrochloride 25 mg  | 99.65%

TargetMol

S1RA HCl (E-52862 HCl) is an effective and specific sigma-1 receptor(σ1R, Ki: 17 nM) antagonist, and has good selectivity against σ2R (Ki > 1000 nM).

More Information Supplier Page

S1RA hydrochloride 10 mg  | 99.65%

TargetMol

S1RA HCl (E-52862 HCl) is an effective and specific sigma-1 receptor(σ1R, Ki: 17 nM) antagonist, and has good selectivity against σ2R (Ki > 1000 nM).

More Information Supplier Page

Autophinib 5 mg  | 98.83%

TargetMol

Autophinib is a potent autophagy inhibitor with a novel chemotype with IC50 values of 90 and 40 nM for autophagy in starvation induced autophagy assay and rapamycin induced autophagy assay.

More Information Supplier Page

Autophinib 50 mg  | 98.83%

TargetMol

Autophinib is a potent autophagy inhibitor with a novel chemotype with IC50 values of 90 and 40 nM for autophagy in starvation induced autophagy assay and rapamycin induced autophagy assay.

More Information Supplier Page

RAF709 25 mg  | 99.43%

TargetMol

RAF709 is a novel Raf kinase inhibitor with IC50s of 0.5 and 1.8 nM for c-Raf and b-Raf, respectively.

More Information Supplier Page

RAF709 50 mg  | 99.43%

TargetMol

RAF709 is a novel Raf kinase inhibitor with IC50s of 0.5 and 1.8 nM for c-Raf and b-Raf, respectively.

More Information Supplier Page